Melissa Layman serves as Executive at Flexion Therapeutics Inc, where they oversee executive responsibilities. Since joining the company, Melissa Layman has executed 6 insider transactions totaling $86.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 19, 2021 involved selling 103,956 shares valued at $883.6K.
Melissa Layman currently holds 103,956 shares of Flexion Therapeutics Inc (FLXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Melissa Layman has been a net seller of FLXN stock. They have purchased $0 and sold $86.3K worth of shares.
Melissa Layman's most recent insider trade was on Nov 19, 2021, when they sold 103,956 shares at $8.50 per share.
Get notified when new Form 4 filings are submitted
| $11.80 |
| Discretionary |
| Mar 1, 2021 | FLXN | $0 | Award | 20,100 | $N/A | Discretionary |
| Jan 28, 2021 | FLXN | $32.9K | Sale | 2,624 | $12.55 | Discretionary |
| Jan 27, 2021 | FLXN | $0 | Award | 30,000 | $N/A | Discretionary |
| Apr 1, 2020 | FLXN | $0 | Award | 61,000 | $N/A | Discretionary |